These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 15150616)
21. Indicators of sexual and somatic development and adolescent body size in relation to prostate cancer risk: results from a case-control study. Barba M; Terrenato I; Schünemann HJ; Fuhrman B; Sperati F; Teter B; Gallucci M; D'Amato A; Muti P Urology; 2008 Jul; 72(1):183-7. PubMed ID: 18280559 [TBL] [Abstract][Full Text] [Related]
22. Physical activity and the risk of prostate cancer in the Netherlands cohort study, results after 9.3 years of follow-up. Zeegers MP; Dirx MJ; van den Brandt PA Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1490-5. PubMed ID: 15941961 [TBL] [Abstract][Full Text] [Related]
23. Obesity, adipokines, and prostate cancer in a prospective population-based study. Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332 [TBL] [Abstract][Full Text] [Related]
24. Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Engeland A; Tretli S; Hansen S; Bjørge T Am J Epidemiol; 2007 Jan; 165(1):44-52. PubMed ID: 17041129 [TBL] [Abstract][Full Text] [Related]
25. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Hammarsten J; Högstedt B Eur J Cancer; 2005 Dec; 41(18):2887-95. PubMed ID: 16243513 [TBL] [Abstract][Full Text] [Related]
26. Sociodemographic status, stress, and risk of prostate cancer. A prospective cohort study. Nielsen NR; Kristensen TS; Zhang ZF; Strandberg-Larsen K; Schnohr P; Grønbaek M Ann Epidemiol; 2007 Jul; 17(7):498-502. PubMed ID: 17448677 [TBL] [Abstract][Full Text] [Related]
27. Obesity and prostate cancer. Harv Mens Health Watch; 2007 Jan; 11(6):1-3. PubMed ID: 17323487 [No Abstract] [Full Text] [Related]
28. Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916. Montgomery RB; Goldman B; Tangen CM; Hussain M; Petrylak DP; Page S; Klein EA; Crawford ED; J Urol; 2007 Nov; 178(5):1946-51; discussion 1951. PubMed ID: 17868721 [TBL] [Abstract][Full Text] [Related]
29. [Prostate cancer--incidence and risk factors]. Brasso K Ugeskr Laeger; 2007 May; 169(20):1883-6. PubMed ID: 17553361 [TBL] [Abstract][Full Text] [Related]
30. Split prostate cancer four ways, Willett says. Tuma RS J Natl Cancer Inst; 2006 Jul; 98(14):959-60. PubMed ID: 16849678 [No Abstract] [Full Text] [Related]
31. Hypertriglyceridemia as a possible risk factor for prostate cancer. Wuermli L; Joerger M; Henz S; Schmid HP; Riesen WF; Thomas G; Krek W; Cerny T; Gillessen S Prostate Cancer Prostatic Dis; 2005; 8(4):316-20. PubMed ID: 16158078 [TBL] [Abstract][Full Text] [Related]
32. Prostate cancer: three research advances. Harv Mens Health Watch; 2002 Jun; 6(11):7. PubMed ID: 12079805 [No Abstract] [Full Text] [Related]
33. Epidemiology of prostate cancer in two European countries: Scotland and Norway. Galletly C; Whyte F Eur J Cancer Care (Engl); 1998 Dec; 7(4):240-6. PubMed ID: 9919111 [TBL] [Abstract][Full Text] [Related]
34. Cruciferous vegetables and prostate cancer risk: confounding by PSA screening. Kristal AR; Stanford JL Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1265. PubMed ID: 15247142 [No Abstract] [Full Text] [Related]
35. Relationship between body size and prostate cancer in a sibling based case-control study. Liu X; Rybicki BA; Casey G; Witte JS J Urol; 2005 Dec; 174(6):2169-73. PubMed ID: 16280757 [TBL] [Abstract][Full Text] [Related]
36. Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer. Tuohimaa P; Tenkanen L; Syvälä H; Lumme S; Hakulinen T; Dillner J; Hakama M Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):302-7. PubMed ID: 17301263 [TBL] [Abstract][Full Text] [Related]
37. Who is the average patient presenting with prostate cancer? Greene KL; Cowan JE; Cooperberg MR; Meng MV; DuChane J; Carroll PR; Urology; 2005 Nov; 66(5 Suppl):76-82. PubMed ID: 16194711 [TBL] [Abstract][Full Text] [Related]
38. Birth characteristics and risk of prostate cancer: the contribution of genetic factors. Cnattingius S; Lundberg F; Sandin S; Grönberg H; Iliadou A Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2422-6. PubMed ID: 19690187 [TBL] [Abstract][Full Text] [Related]
39. Social inequality and incidence of and survival from male genital cancer in a population-based study in Denmark, 1994-2003. Marså K; Johnsen NF; Bidstrup PE; Johannesen-Henry CT; Friis S Eur J Cancer; 2008 Sep; 44(14):2018-29. PubMed ID: 18667299 [TBL] [Abstract][Full Text] [Related]